The administrative core will be led by the PI, Peter Palese, with partial support by an experienced administrator, Nina Umerah, who will have space in the departmental office of the Department of Microbiology at the Mount Sinai School of Medicine. The core will facilitate communication among the participants of the P01 and will be responsible for obtaining permits required by regulatory bodies both inside and outside of the institution. The core will also be responsible for coordinating technology transfer issues arising from the work done with the support of the P01, organizing interactions of the Pis with the External Advisory Board, and building a website. Ms. Umerah is highly skilled in IT and thus will be a great help in allowing a smooth operation of this program.

Public Health Relevance

This program is aimed at developing novel broadly protective influenza virus vaccines which may result in improved and longer lasting influenza vaccine approaches.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
1P01AI097092-01A1
Application #
8410646
Study Section
Special Emphasis Panel (ZAI1-RB-M (M1))
Project Start
Project End
Budget Start
2012-08-01
Budget End
2013-07-31
Support Year
1
Fiscal Year
2012
Total Cost
$91,123
Indirect Cost
$22,388
Name
Icahn School of Medicine at Mount Sinai
Department
Type
DUNS #
078861598
City
New York
State
NY
Country
United States
Zip Code
10029
García-Sastre, Adolfo (2017) Ten Strategies of Interferon Evasion by Viruses. Cell Host Microbe 22:176-184
He, Wenqian; Chen, Chi-Jene; Mullarkey, Caitlin E et al. (2017) Alveolar macrophages are critical for broadly-reactive antibody-mediated protection against influenza A virus in mice. Nat Commun 8:846
Martín-Vicente, María; Medrano, Luz M; Resino, Salvador et al. (2017) TRIM25 in the Regulation of the Antiviral Innate Immunity. Front Immunol 8:1187
Jacobsen, Henning; Rajendran, Madhusudan; Choi, Angela et al. (2017) Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for In Vivo Protection in a Serum Transfer Mouse Challenge Model. MBio 8:
Wohlbold, Teddy John; Podolsky, Kira A; Chromikova, Veronika et al. (2017) Broadly protective murine monoclonal antibodies against influenza B virus target highly conserved neuraminidase epitopes. Nat Microbiol 2:1415-1424
Ermler, Megan E; Kirkpatrick, Ericka; Sun, Weina et al. (2017) Chimeric Hemagglutinin Constructs Induce Broad Protection against Influenza B Virus Challenge in the Mouse Model. J Virol 91:
Schotsaert, Michael; García-Sastre, Adolfo (2017) Inactivated influenza virus vaccines: the future of TIV and QIV. Curr Opin Virol 23:102-106
Klausberger, Miriam; Tscheliessnig, Rupert; Neff, Silke et al. (2016) Globular Head-Displayed Conserved Influenza H1 Hemagglutinin Stalk Epitopes Confer Protection against Heterologous H1N1 Virus. PLoS One 11:e0153579
Chen, Chi-Jene; Ermler, Megan E; Tan, Gene S et al. (2016) Influenza A Viruses Expressing Intra- or Intergroup Chimeric Hemagglutinins. J Virol 90:3789-93
Ajmani, Gaurav S; Suh, Helen H; Pinto, Jayant M (2016) Effects of Ambient Air Pollution Exposure on Olfaction: A Review. Environ Health Perspect 124:1683-1693

Showing the most recent 10 out of 76 publications